Somatic Mutational Analysis by Exome Sequencing Late-Stage Endometrioid Endometrial Carcinoma
Demographics (1)
- sex - Gender of participant (phv00266000.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject (phv00265995.v1.p1)
Other (14)
- ANALYTE TYPE - Analyte type (phv00266003.v1.p1)
- BODY SITE - Body site where sample was collected (phv00266002.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00265994.v1.p1)
- HISTOLOGICAL TYPE - Cell or tissue type or subtype of sample (phv00266005.v1.p1)
- IS_TUMOR - Tumor status (phv00266004.v1.p1)
- PRIMARY TUMOR LOCATION - Primary tumor location (phv00266007.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00266006.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00266001.v1.p1)
- SAMPLE_ID - Sample ID (phv00265997.v1.p1)
- SAMPLE_USE - Sample Use (phv00265998.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00266008.v1.p1)
- SUBJECT_ID - Subject ID (phv00265993.v1.p1)
- SUBJECT_ID - Subject ID (phv00265996.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00265999.v1.p1)